JP2018527932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527932A5 JP2018527932A5 JP2018511706A JP2018511706A JP2018527932A5 JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5 JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5
- Authority
- JP
- Japan
- Prior art keywords
- treg cells
- human
- ifnγ
- cd45rc low
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021133065A JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15306366 | 2015-09-07 | ||
| EP15306366.4 | 2015-09-07 | ||
| PCT/EP2016/070991 WO2017042170A1 (en) | 2015-09-07 | 2016-09-06 | A new subpopulation of cd8+cd45rclow tregs and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Division JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527932A JP2018527932A (ja) | 2018-09-27 |
| JP2018527932A5 true JP2018527932A5 (enExample) | 2019-09-26 |
Family
ID=54196910
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511706A Pending JP2018527932A (ja) | 2015-09-07 | 2016-09-06 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180251731A1 (enExample) |
| EP (1) | EP3347452B1 (enExample) |
| JP (2) | JP2018527932A (enExample) |
| KR (1) | KR102768442B1 (enExample) |
| CN (1) | CN108291203A (enExample) |
| AU (1) | AU2016318762B2 (enExample) |
| BR (1) | BR112018004454A2 (enExample) |
| CA (1) | CA2997646C (enExample) |
| ES (1) | ES2890818T3 (enExample) |
| IL (1) | IL257891B (enExample) |
| MX (1) | MX390494B (enExample) |
| WO (1) | WO2017042170A1 (enExample) |
| ZA (1) | ZA201801265B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3042179A1 (en) * | 2016-10-31 | 2018-05-03 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene |
| CN118662615A (zh) | 2017-03-15 | 2024-09-20 | 浩康生物系统公司 | 用于造血干细胞移植的组合物和方法 |
| EP3652306A1 (en) * | 2017-07-13 | 2020-05-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for increasing expansion and immunosuppressive capacity of a population of cd8+cd45rclow/-tregs |
| CN111684061B (zh) | 2018-01-19 | 2024-07-30 | 美天施生物科技有限两合公司 | 表达嵌合抗原受体的调节性t细胞 |
| ES3012854T3 (en) | 2018-02-08 | 2025-04-10 | Univ Leland Stanford Junior | Allogenic hematopoietic stem cell transplantation |
| US11141435B2 (en) * | 2018-03-14 | 2021-10-12 | Thermogenesis Corporation | Buoyancy-activated cell sorting (BACS)-compatible activation/transduction systems and methods |
| WO2020102503A2 (en) | 2018-11-14 | 2020-05-22 | Flagship Pioneering Innovations V, Inc. | Fusosome compositions for t cell delivery |
| EP3894543A1 (en) * | 2018-12-14 | 2021-10-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8cd45rc low tregs |
| EP3963053A4 (en) * | 2019-04-30 | 2023-01-18 | The Regents of the University of California | PEARL-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T-CELLS |
| EP4013780A4 (en) * | 2019-08-14 | 2024-04-10 | The Regents Of The University Of California | CAR-T CELLS SPECIFIC FOR MODIFIED PROTEINS IN EXTRACELLULAR SPACES |
| US20230147657A1 (en) * | 2020-03-20 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Chimeric antigen receptor specific for human cd45rc and uses thereof |
| WO2024028486A1 (en) * | 2022-08-04 | 2024-02-08 | Nantes Universite | In vitro method for obtaining clinical-grade cd8+ cd45rclow/- regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE460475T1 (de) * | 2000-04-11 | 2010-03-15 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
| PT2126054T (pt) * | 2007-01-31 | 2016-10-12 | Yeda Res & Dev | Células t reguladoras geneticamente modificadas, redirecionadas e sua utilização na supressão de doenças inflamatórias e autoimunitárias |
| US10137181B2 (en) * | 2014-04-01 | 2018-11-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolated donor MHC-derived peptide and uses thereof |
| JP6769948B2 (ja) * | 2014-07-17 | 2020-10-14 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 移植拒絶の予防及び自己免疫疾患の治療に使用するための単離されたインターロイキン−３４ポリペプチド |
-
2016
- 2016-09-06 US US15/758,139 patent/US20180251731A1/en not_active Abandoned
- 2016-09-06 AU AU2016318762A patent/AU2016318762B2/en active Active
- 2016-09-06 CN CN201680064881.0A patent/CN108291203A/zh active Pending
- 2016-09-06 EP EP16769882.8A patent/EP3347452B1/en active Active
- 2016-09-06 KR KR1020187009677A patent/KR102768442B1/ko active Active
- 2016-09-06 WO PCT/EP2016/070991 patent/WO2017042170A1/en not_active Ceased
- 2016-09-06 ES ES16769882T patent/ES2890818T3/es active Active
- 2016-09-06 JP JP2018511706A patent/JP2018527932A/ja active Pending
- 2016-09-06 MX MX2018002849A patent/MX390494B/es unknown
- 2016-09-06 CA CA2997646A patent/CA2997646C/en active Active
- 2016-09-06 BR BR112018004454A patent/BR112018004454A2/pt not_active Application Discontinuation
-
2018
- 2018-02-23 ZA ZA2018/01265A patent/ZA201801265B/en unknown
- 2018-03-05 IL IL257891A patent/IL257891B/en active IP Right Grant
-
2021
- 2021-08-18 JP JP2021133065A patent/JP7254128B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sullivan et al. | Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance | |
| Beres et al. | The role of regulatory T cells in the biology of graft versus host disease | |
| Kelsen et al. | FoxP3+ CD4+ CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease | |
| Das et al. | Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease | |
| Putnam et al. | Expansion of human regulatory T-cells from patients with type 1 diabetes | |
| Björkström et al. | Tissue‐specific effector functions of innate lymphoid cells | |
| Ishikawa et al. | Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease | |
| Roberts et al. | TNF blockade maintains an IL-10+ phenotype in human effector CD4+ and CD8+ T cells | |
| Davies et al. | Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release | |
| Castillo et al. | A new method for reactivating and expanding T cells specific for Rhizopus oryzae | |
| Sharma et al. | Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition | |
| CN108463547A (zh) | 通过改变细胞表面信号和信号比选择性扩增不同的t细胞亚群 | |
| JP5937003B2 (ja) | 免疫介在性疾患における臨床応用のための、抑制機能の高められた制御性ｔ細胞のエクスビボ増加方法 | |
| Hu | A framework of all discovered immunological pathways and their roles for four specific types of pathogens and hypersensitivities | |
| Pereira et al. | Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations | |
| Radhakrishnan et al. | BCG vaccination reduces the mortality of Mycobacterium tuberculosis–infected type 2 diabetes mellitus mice | |
| Zhu et al. | Granzyme B producing B-cells in renal transplant patients | |
| Volchenkov et al. | In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome | |
| Domingues et al. | Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus | |
| Lin et al. | Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4+ CD25+ T cells | |
| Mangus et al. | Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity | |
| Li et al. | CD8+ lymphocytes in immunity against tuberculosis | |
| US20250313800A1 (en) | Improved method for preparing tumor-infiltrating lymphocyte | |
| Jin et al. | Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells | |
| Kidzeru et al. | Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infants |